What Factors Are Escalating the Demand Across the Adeno-Associated...

σε πρόσθεσε στο Iniciativas de Impacto

2026-09-24 14:57:54 -

What Factors Are Escalating the Demand Across the Adeno-Associated Virus Vector-Based Gene Therapy Market?

The increasing prevalence of genetic disorders and the growing adoption of gene therapy have propelled substantial expansion in the AAV vector-based gene therapy domain. According to detailed industry evaluation, the Adeno-Associated Virus (AAV) Vector-Based Gene Therapy Market was valued at USD 5.718 billion in 2024 and is projected to reach USD 70.67 billion by 2035, exhibiting a...

0 Σχόλια 0 Μοιράστηκε 0 Προεπισκόπηση